Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07477509 · ClinicalTrials.gov registry record
Northwestern Neuromuscular Disease Biorepository
A clinical trial of Neuromuscular Diseases (NMD), sponsored by Northwestern University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT07477509: Recruiting study of Neuromuscular Diseases (NMD), sponsored by Northwestern University.
NCT07477509 is a study of Neuromuscular Diseases (NMD) that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 2,500 participants, above the 25-participant average among 3 other Neuromuscular Diseases (NMD) trials with a reported enrollment target (9900% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07477509, a study of Neuromuscular Diseases (NMD), is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this research is to collect clinical data and tissue samples from adult patients with neuromuscular disease cared for at the Northwestern Memorial Hospital neuromuscular clinic (Lavin Building, 19th floor). This study has the following aims: Aim 1: To consent a large cohort of adult study participants with neuromuscular disorders, including but not limited to motor neuron diseases, neuropathies, neuromuscular junction disorders, and myopathies for participation in the biorepository and to collect longitudinal data on their clinical disease phenotypes. Aim 2: To obtain and store biological samples from biorepository study participants, including whole blood, plasma, serum, peripheral blood mononuclear cells \[PBMCs\], skin biopsies, and cerebrospinal fluid. Aim 3: To develop a data-sharing process to provide de-identified biorepository participant clinical data and samples to partnered investigators to expedite discovery in neuromuscular disease diagnosis and treatment.
Primary Outcome
This is a longitudinal registry of biofluid samples paired to categorized clinical data ultimately used to provide sample to partnered basic scientists and accelerate discovery in neuromuscular medicine.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern University Department of Neurology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-03 |
| Est. Completion | 2050-03 |
What NCT07477509 shows while recruiting
NCT07477509 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 25-participant average among 3 other Neuromuscular Diseases (NMD) trials with a reported enrollment target (9900% higher).
The record links to 1 condition, with Neuromuscular Diseases (NMD) appearing as the primary indexed condition, and to 0 interventions.
NCT07477509 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07477509 about?
NCT07477509 is a clinical study titled "Northwestern Neuromuscular Disease Biorepository". The primary objective of this research is to collect clinical data and tissue samples from adult patients with neuromuscular disease cared for at the Northwestern Memorial Hospital neuromuscular clinic (Lavin Building, 19th floor). This study has the following aims: Aim 1: To consent a large cohor...
What is the current status of trial NCT07477509?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2026-03. Estimated completion is 2050-03.
What conditions does trial NCT07477509 study?
This clinical trial studies the following conditions: Neuromuscular Diseases (NMD).
Who is sponsoring clinical trial NCT07477509?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07477509 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Diseases (NMD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
ACTIVE NOT RECRUITING · Phase 1
-
Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia